🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
68.45
+0.73 (1.08%)
At close: Nov 20, 2026, 4:00 PM EST
67.65
-0.80 (-1.17%)
After-hours: Nov 20, 2026, 7:48 PM EST

Royalty Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
39,26316,50911,33412,49717,43217,116
Market Cap Growth
137.77%45.66%-9.30%-28.31%1.85%-11.89%
Enterprise Value
47,30627,72621,33221,13227,33326,687
Last Close Price
68.4537.9924.4626.1235.8335.48

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
44.7021.4113.2011.01407.0027.62
Forward PE
10.497.706.107.4710.3213.00
PS Ratio
15.006.945.015.317.797.48
PB Ratio
4.461.701.101.241.831.67
P/TBV Ratio
6.642.971.631.923.112.97
P/OCF Ratio
13.266.634.094.188.138.48
PEG Ratio
1.110.792.142.650.941.12

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
18.0811.669.428.9812.2211.66
EV/EBITDA Ratio
27.9817.74-14.1129.4418.36
EV/EBIT Ratio
28.0717.7816.5114.1629.6218.65

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.880.920.740.610.750.69
Debt / EBITDA Ratio
5.085.74-4.107.664.88
Net Debt / Equity Ratio
0.820.860.640.560.560.48
Net Debt / EBITDA Ratio
4.765.33-3.775.793.38
Asset Turnover
0.140.130.130.140.130.14
Quick Ratio
1.292.391.437.782.1116.77
Current Ratio
1.292.401.447.902.1916.81
Return on Equity (ROE)
12.09%13.20%13.03%17.34%2.33%12.32%
Return on Assets (ROA)
3.46%4.07%4.96%6.84%0.25%3.70%
Return on Capital Employed (ROCE)
9.20%8.20%7.60%9.20%5.90%8.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
2.24%4.67%7.58%9.08%0.25%3.62%
Dividend Yield
1.37%2.28%3.31%2.86%1.93%1.72%
Payout Ratio
61.38%49.06%43.83%31.57%778.21%46.02%
Buyback Yield / Dilution
16.87%4.99%1.46%-37.66%-5.59%-10.48%
Total Shareholder Return
18.24%7.28%4.76%-34.80%-3.65%-8.76%
SEC Filings: 10-K · 10-Q